
    
      About 70 patients with clinical evidence of ischemic heart disease and / or a positive
      functional study and documented stable angina pectoris (Canadian cardiovascular society
      classification (CCS)1, 2, 3 or 4), or documented silent ischemia in de-novo, native,
      previously unstented vessel in Fuwai Hospital,will be randomly assigned undergoing
      implantation of BuMA stent or EXCEL stent (in a 1:1 ratio).

      All of the patients will receive 6 months dual antiplatelet therapy and they will be followed
      (at the outpatient clinic) for up to 2 years. The follow-up visits will be conducted at 3
      months (including angiographic/OCT investigation), 6 months, 1 and 2 years post percutaneous
      coronary intervention(PCI),in order to observe the Primary Endpoint and Secondary Endpoints.
    
  